• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926008250
Medical Device Problem Codes Bent (1059); Device Damaged Prior to Use (2284)
Health Effect - Clinical Code No Patient Involvement (2645)
Date of Event 04/04/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.A 2.50 x 8 synergy ii drug eluting stent (des) was selected to treat the lesion.However, during preparation, the stent was damaged.The device was not used and the procedure was completed with another of the same device.No patient complications were reported.The patient's status was fine and was discharged in stable condition.
 
Additional Manufacturer Narrative
Device evaluated by mfr: synergy ii us mr 2.50 x 8mm stent delivery system (sds) was returned for analysis.A visual examination of the crimped stent found no issues.There were no signs of damage, lifting or stretching of the stent struts.The stent showed no signs of movement and was set equidistant between the proximal and distal markerbands.The crimped stent od (outer diameter) was measured which is within max crimped stent profile measurement.The balloon cones were reviewed and no issues were noted.A visual and tactile examination of the device found a break in the hypotube at approximately 437mm distal to the strain relief with multiple kinks along the catheter length.An examination of the shaft polymer extrusion found no issues.The bi-component bond showed no signs of damage.The tip was visually and microscopically examined and damage was noted.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is considered handling damage as the event occurred without direct patient contact.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.A 2.50 x 8 synergy ii drug eluting stent (des) was selected to treat the lesion.However during preparation, the stent was damaged.The device was not used and the procedure was completed with another of the same device.No patient complications were reported.The patient's status was fine and was discharged in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key6516450
Report Number2134265-2017-04009
Device Sequence Number1594642
Product Code NIQ
UDI-Device Identifier08714729839972
UDI-Public(01)08714729839972(17)20170926(10)19778702
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/26/2017
Device Model NumberH7493926008250
Device Catalogue Number39260-0825
Device Lot Number19778702
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/17/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 04/05/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/24/2017
Supplement Report FDA Received Date05/18/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age68 YR
-
-